Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation

Description

The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.

Study Start Date

January 2012

Estimated Completion Date

August 2020

Interventions

  • Genetic: response to therapy

Specialties

  • Internal Medicine: Gastroenterology
  • Gastroenterology: Esophagus
  • Family Medicine: Gastroenterology
  • Physician Assistant: Gastroenterology

MeSH Terms

  • Barrett Esophagus

Study ID

Mayo Clinic -- 11-006510

Status

Recruiting

Trial ID

NCT01568723

Study Type

Observational

Trial Phase

N/A

Enrollment Quota

160

Sponsor

Mayo Clinic

Inclusion Criteria

  • Barrett's esophagus with high grade dysplasia or intramucosal (early) adenocarcinoma.
  • BE length ? 2 cm and ? 8 cm.
  • Able to return every 3 months for one year after ablation

Exclusion Criteria

  • Patients who are unable to be compliant with follow-up endoscopies
  • patients who cannot tolerate Proton Pump inhibitors
  • pre-existing esophageal strictures
  • pregnant or nursing women

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

No

Study Locations and Contact Information (1)

Study Location Distance Name Phone Email
Columbia University - New York, New York 44.8 miles None None None

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.